Choice of oseltamivir in 2009 flu pandemic was “worrying,” says MPBMJ 2013; 346 doi: http://dx.doi.org/10.1136/bmj.f3371 (Published 23 May 2013) Cite this as: BMJ 2013;346:f3371
- Zosia Kmietowicz
The MP Margaret Hodge has expressed dismay at the government’s decision in 2009 to stockpile oseltamivir (sold as Tamiflu) in preparation for a flu pandemic despite uncertainty over the drug’s effectiveness.
Hodge, who chairs the House of Commons Public Accounts Committee, said she was also appalled at the “squandering” of £74m (€86m; $112m) of taxpayers’ money when 6.5 million doses of oseltamivir had to be written off because of the NHS’s poor record keeping on how the drug was stored during the 2009-10 pandemic. “There is simply no excuse for this waste,” she said.
Hodge was responding to a memorandum from the National Audit Office written to inform members of her committee on how drugs are licensed and the reasoning behind the decision of the Department of …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial